Skip to content

NIDEC PHARMA

Absorbed by SOPHADE KBO/BCE: BE 0468.086.267 subsidiary of SOPHADE

Last board

2 directors, 2 in day-to-day management, last change in 2023
Managing director
in office according to the deed of 12-10-2023
also on the board of 1 other company
listed in the 2023 annual accounts, filed on 22-08-2024
Managing director, permanent representative
managing director in office according to the deed of 12-10-2023 managing director in office according to the deed of 08-08-2017
listed in the 2023 annual accounts, filed on 22-08-2024
,
Permanent representatives 1
Permanent representative, for
in office according to the deed of 12-10-2023
also on the board of 1 other company

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today

Managing director, Director

Director, Managing director
LeadershipBoardmandate already running before its first mention
Mandates as a list
    • Managing director, since before 12-06-2017
    • Director, since before 08-08-2017
    • Director, since before 08-08-2017
    • Managing director, since before 12-06-2023

Control

Parent
Equity €344,187
Loss €58,202 in 2025 (loss €33,669 in 2024)
Checked score
Source: deed 28-02-2024
100%
This company
NIDEC PHARMA
Equity -€572,157
Profit €62,618 in 2023

Capital

Capital
€61,973.38
Source
2023 annual accounts

Owners through the years

as the annual accounts name them
100%
Owners as a list
    • 2011 to 2023: 100%

Source: lists of holdings in the owners' accounts

Capital transactions

Shareholders according to the deeds
Stated in the deed deed of 08-05-2024 ↗
  • all shares
Stated in the deed deed of 28-02-2024 ↗
  • all shares · 100%

Next steps